Proficio Capital Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Proficio Capital Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-157	Closed	-$10K	–	811
2019 Q2	$10K	Buy	157 +42	+37%	+$2.97K	﹤0.01%	929
2019 Q1	$9K	Hold	115	–	–	﹤0.01%	912
2018 Q4	$6K	Buy	115 +43	+60%	+$2.19K	﹤0.01%	828
2018 Q3	$4K	Buy	72 +10	+16%	+$470	﹤0.01%	990
2018 Q2	$3K	Buy	62 +34	+121%	+$1.51K	﹤0.01%	1078
2018 Q1	$1K	Hold	28	–	–	﹤0.01%	1202
2017 Q4	$1K	Hold	28	–	–	﹤0.01%	1187
2017 Q3	$1K	Hold	28	–	–	﹤0.01%	1177
2017 Q2	$1K	Hold	28	–	–	﹤0.01%	1180
2017 Q1	$1K	Hold	28	–	–	﹤0.01%	1216
2016 Q4	$1K	Hold	28	–	–	﹤0.01%	1020
2016 Q3	$1K	Hold	28	–	–	﹤0.01%	971
2016 Q2	$1K	Sell	28 -39	-58%	-$1.26K	﹤0.01%	906
2016 Q1	$3K	Buy	67 +39	+139%	+$1.58K	﹤0.01%	637
2015 Q4	$2K	Buy	+28	New	+$1.51K	﹤0.01%	654

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Proficio Capital Partners's IONS Position: Q3 2019 in Review

Proficio Capital Partners sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 157 shares — an estimated $10K sold.

Proficio Capital Partners first reported a position in IONS in Q4 2015 and held it in 15 quarters. The position peaked at $10K in Q2 2019. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

Proficio Capital Partners reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Proficio Capital Partners sold 157 Ionis Pharmaceuticals shares in Q3 2019, an estimated $10K.
Proficio Capital Partners first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 15 quarters.
Proficio Capital Partners's Ionis Pharmaceuticals position peaked at $10K in Q2 2019.
369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.